Dominique Missiakas

This inventor holds 20 USPTO granted patents and 14 published patent applications, plus 3 CIPO patents and 7 EPO patents, primarily in Staphylococcal Infections. Top assignees: The University of Chicago, Janssen Pharmaceuticals, Inc.. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dominique Missiakas. Retrieved from https://idiyas.com/inventor/dominique-missiakas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 (Patent Applications = 14)

% Patents Active = 100.0

CIPO Patents = 3 (Patent Applications = 3)

EPO Patents = 7 (Patent Applications = 17)

Average Co-Inventor Count = 4.3

ph-index = 5

Forward Citations = 70(Granted Patents)

Company Filing History:

20 out of 965

The University of Chicago

patents

1 out of 161

Janssen Pharmaceuticals, Inc.

patents

where one patent can have more than one assignee

Years Active: 2014-2026

Loading Chart...

Areas of Expertise:

Staphylococcal Infections

Protein A Variants

Coagulase Activity

Antibody Compositions

Immune Response

Staphylococcal Antigens

Neutralization

Protective Antigens

Antibody Enhancement

Compositions

Methods

Variants

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12528882 - METHODS AND COMPOSITIONS FOR TREATING STAPHYLOCOCCAL INFECTIONS (2026-01-20),

2. 12514914 - METHODS AND COMPOSITIONS COMPRISING STAPHYLOCOCCUS PROTEIN A (SPA) VARIANTS (2026-01-06),

3. 11939358 - Compositions and methods related to protein A (SpA) variants (2024-03-26),

4. 11214600 - Compositions and methods related to antibodies that neutralize coagulase activity duringdisease (2022-01-04),

5. 11059866 - Compositions and methods related to protein A (SpA) variants (2021-07-13),

6. 10857220 - Staphylococcal coagulase antigens and methods of their use (2020-12-08),

7. 10464971 - Compositions and methods related to Protein A (SpA) Variants (2019-11-05),

8. 10047149 - Compositions and methods related to antibodies to Staphylococcal protein A (2018-08-14),

9. 9968668 - Staphylococcal coagulase antigens and methods of their use (2018-05-15),

10. 9907850 - Compositions and methods related to protein A (SpA) antibodies as an enhancer of immune response (2018-03-06),

11. 9701738 - [object Object] (2017-07-11),

12. 9567379 - Compositions and methods related to protein A (SpA) variants (2017-02-14),

13. 9556281 - Compositions and methods related to antibodies to staphylococcal protein A (2017-01-31),

14. 9315554 - Compositions and methods related to protein A (SpA) variants (2016-04-19),

15. 9212219 - Compositions and methods related to protein A (SpA) antibodies as an enhancer of immune response (2015-12-15),

Title: The Innovative Journey of Dominique Missiakas

Introduction: Dominique Missiakas, a talented inventor based in Chicago, IL, has made significant contributions to the field of innovation with his groundbreaking ideas and inventions.

Latest Patents: Dominique Missiakas holds several patents in various industries, showcasing his diverse range of expertise and creativity in inventing new solutions to complex problems.

Career Highlights: With a career spanning over two decades, Dominique Missiakas has established himself as a prominent figure in the innovation landscape, consistently pushing the boundaries of what is possible through his inventive spirit.

Collaborations: Throughout his career, Dominique Missiakas has collaborated with leading companies, research institutions, and universities to bring his ideas to life, fostering a culture of innovation and excellence in all his endeavors.

Conclusion: Dominique Missiakas continues to inspire the next generation of inventors with his passion for innovation and his relentless pursuit of turning ideas into reality, leaving a lasting impact on the world of inventions.

Profile summary based on public USPTO records.